Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history.
Ota K, Murakami S, Ishihara K, Sasaki D, Usui T, Mitsumoto-Kaseida F, Sakamoto K, Kosai K, Hasegawa H, Takazono T, Furumoto A, Asoh N, Yoshimine H, Sawai T, Onizuka M, Makimoto N, Izumikawa K, Mukae H, Kohno S, Yanagihara K.
Ota K, et al. Among authors: yoshimine h.
Vaccine X. 2023 Apr;13:100282. doi: 10.1016/j.jvacx.2023.100282. Epub 2023 Mar 17.
Vaccine X. 2023.
PMID: 36960104
Free PMC article.